Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Return on Equity (2016 - 2025)

Apyx Medical (APYX) has disclosed Return on Equity for 15 consecutive years, with 1.07% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 125.0% year-over-year to 1.07%, compared with a TTM value of 1.07% through Dec 2025, down 125.0%, and an annual FY2025 reading of 0.76%, down 87.0% over the prior year.
  • Return on Equity was 1.07% for Q4 2025 at Apyx Medical, down from 1.69% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.69% in Q3 2025 and bottomed at 2.18% in Q3 2024.
  • Average Return on Equity over 5 years is 0.37%, with a median of 0.4% recorded in 2022.
  • The sharpest move saw Return on Equity crashed -175bps in 2024, then skyrocketed 387bps in 2025.
  • Year by year, Return on Equity stood at 0.28% in 2021, then plummeted by -108bps to 0.58% in 2022, then dropped by -7bps to 0.62% in 2023, then soared by 128bps to 0.17% in 2024, then plummeted by -722bps to 1.07% in 2025.
  • Business Quant data shows Return on Equity for APYX at 1.07% in Q4 2025, 1.69% in Q3 2025, and 0.94% in Q2 2025.